Skip to main content

Table 1 Clinical characteristics of the study groups

From: Clinical implications of the quantitative detection of ID4 gene methylation in myelodysplastic syndrome

Group Number of patients (total n= 142)
NBM 20
MDS-AL 22
MDS 100
WHO subtype 100
 Low-risk 70
RA 41
 RARS 7
 RCMD 22
 High-risk 30
RAEB-1 21
RAEB-2 9
IPSS risk group 35
 Low-risk 24
 Low 2
 Int-1 22
 High-risk 11
 Int-2 11
 High 0
Karyotype  
 Good 22
 Poor 6
  1. NBM, normal bone marrow; MDS, myelodysplastic syndrome; AL, acute leukemia; RA, refractory anemia; RARS, refractory anemia with ringed sideroblasts; RCMD, refractory cytopenia with multilineage dysplasia; RCMD-RS, refractory cytopenia with multilineage dysplasia and ringed sideroblasts; RAEB, refractoryanemia with excess of blasts; IPSS, International Prognostic Scoring System.